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ansemia, was caused by the barbiturates she was taking.
Both amylobarbitone sodium and quinalbarbitone sodium,
the constituents of tuinal, are closely related chemically
to primidone, sodium phenytoin, and phenobarbitone,
but a megaloblastic anaemia has not previously been
described in association --ith their use. The doses that
this patient was taking (gr. 18-20 for 6-8 months)
were, however, in excess of the usual doses given.
In view of the accumulating evidence that barbiturates
interfere with the metabolism of folic acid, it appears
desirable that the signs of early folic-acid deficiency
should be sought in all patients who receive large doses
of barbiturates for any length of time.
Summary
A woman, aged 30, who had acquired the habit of
taking large doses of amylobarbitone sodium and quinal-
barbitone sodium became critically ill with severe
megaloblastic anaemia. Her serum-vitamin-B12 level
before treatment was normal, and she did not respond
to treatment with vitamin B12. Her ansemia, however,
responded rapidly to treatment with folic acid.
Her diet was adequate and no significant impairment
of intestinal absorption was found.
We wish to thank Dr. I. Chanarin, of the ’department of
pathology* (haematology) for the folic-acid assay; Dr. E.
Lester Smith, of the research division of Glaxo Laboratories
Ltd., for the labelled vitamin B12 ; and Miss Barbara
Anderson, B.sc., for help with the radioactive measurements.
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zine, a synthetic compound, is a new tranquillisingdrug recently introduced in this country. because
of the increasing and widespread use of such drugs it
seems desirable .to draw attention to any serious com-
plication which may arise during their use. We are
therefore reporting the following case of agranulocytosis
developing during treatment with pacatal :
A married woman, aged 35, was admitted to this hospital
on June 4, 19P6, with about a year’s history of severe
depisssion.-She was in good physical health. On this occasioii,
as on two previous admissions, she did not respond to electro-
convulsive therapy.
Treatment with pacatal 25 mg. three times daily was begun
on July 10 and the dosage was increased to 50 mg. three
times daily on July 24. On Aug. 23, after 5-55 g. of pacatal
had been given, this treatment was stopped because a routine
blood-count showed 3000 white cells per c.mm. (polymorphs
53%).
Progress.-A week later she had 2600 white cells per c.rnrn.
Two days later, on Sept. 1, the patient complained of sore
throat and headache and looked pale and ill. She had a
temperature of 99&deg;F, pulse-rate 100, and respirations 22 a
minute. Her pharynx and fauces were inflamed. Examina-
tion of the blood showed Hb 83% and white cells 900 per
c.mm. (polymorphs 1%). She was given intramuscular
injections of sodium pentose nucleotide 10 ml. and penicillin
500,000 units every six hours. During the next three days
she had irregular low-grade pyrexia and developed necrotic
pharyngeal ulcers. On Sept. 4 streptomycin was given in addi-
tion to penicillin because a profuse growth of Escherichia coli
resistant to penicillin but sensitive to streptomycin was
cultured from her throat. At this time there was a definite
improvement in her general condition, and from then on
her white-cell count rapidly returned to normal. Nine days
after the diagnosis had been made no abnormality was found.
The changes in her blood picture were as follows :
Since this patient developed agranulocytosis during
treatment with pacatal, it seemed reasonable to conclude
that there was a causal relationship between the drug
and the development of this serious complication.
So far as we know, no account of agranulocytosis due to
pacatal has yet been published in this country, perhaps
because of the lag between the introduction of a new
drug and the discovery of dangerous side-effects. It
is clearly important to do routine blood-counts on
patients treated with pacatal and to caution them to
report any departure from their customary state of
physical health, such as the development of fever, sore
throat, or local sepsis.
We are grateful to Dr. 1. R. Nussbaum for permission to
publish, and to the laboratory staff of Rainhill Hospital for
the investigations. ,
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DURING investigations into the acute effects of cortico-
 trophin and adrenocortical steroids on gastric secretion
(Hirschowitz et al. 1955a), one of the subjects of our
experiments developed a prepyloric gastric ulcer. The
findings are presented here because there is little published
information about changes in gastric secretion and- in
pepsinogen levels in the plasma and the urine before and
immediately after exacerbations of peptic ulcer.
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Fig. 1&mdash;Changes in gastric secretion and urine-pepsinogen and plasma-
pepsinogen levels before, during, and after healing of steroid-induced
prepyloric gastric ulcer.
The course of the ulcer and the laboratory findings in
this patient were strikingly similar to those seen in
another subject, who developed a postbulbar duodenal
ulcer while receiving corticotrophin (Hirschowitz et al.
1955b), and lend support to the conclusions drawn from
the earlier observations on the genesis and healing of
steroid-induced ulcers.
Methods
The patient had four 13-hour studies (on days 1, 8, 20,
and 27) in which basal gastric secretion was measured.
In the first study the vehicle alone (1-0% alcohol and
Fig. 2-Stomach radiographs : (a) on day 3), showing prepyloric crater
(arrow) on 4th day of symptoms ; and (b) on day 35, showing com-
plete healing of ulcer.
2.5% dextrose in 0.45% saline solution) was infused for
13 hours. In the subsequent three studies infusion of
the vehicle alone for 5 hours was followed by infusions,
during 8 hours, of hydrocortisone 100 mg., corticosterone
100 mg., and corticotrophin 25 i.u., each in 1000 ml. of
vehicle.
The volume, acid content, pepsin content, and viscosity
of the gastric juice, as well as the plasma and urinary
pepsinogen, were measured by the methods previously
described (Hirschowitz et al. 1955b, Hirschowitz 1955).
Buffering capacity of samples of gastric juice of pH over
3.5 was measured by electrometric titration against
01 N hydrochloric acid to pH 3-5.
Sodium and potassium concentrations were measured
on the Baird internal standard flame photometer;
eosinophils were counted by using phloxine in propylene
glycol ; and plasma-cholinesterase levels were estimated
by the method of Michel (1949).
Case-report ’
The subject was a male medical student, aged 23, who had
had no previous gastric symptoms of any kind. The mean
changes from the control values induced by hydrocortisone,
corticosterone, and corticotrophin in the hourly output of
hydrochloric acid and of pepsin are indicated in fig. 1 by the
vertical lines at each point : hydrocortisone caused a small
decrease in both hydrochloric acid and pepsin, whereas
corticosterone and corticotrophin caused a moderate increase
in both. In none of these experiments was there any unusual
response in the eosinophil-count, hsematocrit, urinary electro-
lytes (Na and K), or excretion of pepsinogen, or any change
in plasma-pepsinogen or plasma-cholinesterase levels, either
before or immediately after development of the ulcer. During
the experimental period and until 4 days after the last experi.
ment (corticotrophin) the subject of the experiment had no
symptoms.
Onset and Cotirse.-On the morning of the 5th day after
corticotrophin he complained of epigastric pain, hypersaliva.
tion, and nausea. Solid food aggravated the pain for the
first day or two, and milk afforded partial relief, but the pain
persisted despite the patient’s taking ’ Probanthine’ 15 mg.
thrice daily for the first 2 days. He took no other medication,
and therapy after the first 2 days was confined to a bland
diet for the next week. A radiograph of the upper-gastro-
intestinal tract on the 4th day after the onset of symptoms
showed a moderately large prepyloric crater (fig. 2a). 3 days
later the patient had no symptoms, and radiography next day
showed that the ulcer was completely healed (fig. 2b). No
further symptoms developed in the next 15 months.
Laboratory Findings.&mdash;No laboratory studies were made in
the 4 days preceding the onset of symptoms or in the 2 follow-
ing days. Serial daily 1-hour basal gastric analyses were
obtained in the next 5 days and three more in the next
5 months (see fig. 1). The changes in gastric secretion and
in plasma and urinary pepsinogen immediately after the onset
of the ulcer were striking and almost identical with those
in a similar case reported previously (Hirschowitz et al. 1955b).
The secretion of hydrochloric acid ceased, pepsin secretion
diminished, and the viscosity of the gastric juice increased to
the point where some specimens had to be cut with scissors
to allow separation of samples for pH measurements. At the
same time the plasma-pepsinogen and urine-pepsinogen levels,
which had been normal 4 days before the ulcer appeared,
rose extremely high. 2 months after the ulcer had healed the
basal gastric juice still contained no acid and little pepsin,
and the plasma-pepsinogen and urine-pepsinogen levels were
still moderately raised. Five months after the ulcer, gastric
secretion and the plasma-pepsinogen and urine-pepsinogen
levels had reverted to normal.
Discussion
As in the similar case of a corticotrophin-induced ulcer
reported previously (Hirschowitz et al. 1955b), no
abnormalities in the volume or composition of gastric
secretion or in the plasma-pepsinogen and urine-pep-
sinogen levels were noted in the 4 weeks preceding the
onset of the ulcer ; though the possibility cannot be ruled
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out that changes may have taken place in the 4 days
immediately before symptoms started.
The changes after the ulcer were very similar to those
seen in the previously reported case and consisted in an
initial hypersalivation, probably manifesting vagal over-
activity, followed shortly by achlorhydria and a decrease
in pepsin, and a great increase in gastric mucus. The
decrease in gastric pepsin contrasted with the increases
in plasma-pepsinogen and urine-pepsinogen levels, sug-
gesting a reversal of the secretion gradient of the peptic
(chief) cells of the gastric mucosa.
The ulcer healed rapidly, and there was radiological
evidence of healing (fig. 2b) of the ulcer 4 days after a
crater was seen and 7 days after the first symptoms.
There is no evident difference between the manifesta-
tions of these corticotrophin-induced ulcers and those of
many spontaneous ulcers. It is therefore possible that
a "spontaneous" peptic ulcer may be initiated by
endogenous release of corticotrophin in response to
physical or mental stress (Gray et a]. 1951). Our observa-
tions, however, provide no support for the view that the
i6te of corticotrophin in the genesis of peptic ulcer is
mediated by any abnormal changes in the secretion of
acid or of pepsin by the stomach.
The reason why some acute ulcers heal rapidly while
others relapse and become chronic is unknown. Some
inkling of a possible mechanism for the emergence of
chronicity in ulcers is provided by the observed changes
in the composition of gastric juice in the two patients
whose ulcers healed so promptly. The healing was in
each instance associated with virtually complete substi-
tution of thick mucus for the normal constituents of the
gastric juice. In contrast, most patients with chronic
duodenal ulcers continue to secrete gastric juice with
relatively high concentrations of acid and normal con-
centrations of pepsin. Though there is no evidence that
an increased secretion of acid and pepsin precedes and
causes the initial or recurrent breakdown of the gastric
or duodenal mucosa, it is quite conceivable that the
continued secretion of acid and pepsin may prevent the
healing of an ulcer which would have healed rapidly if
mucus had taken the place of acid and pepsin in the
gastric juice. The cause of failure to heal and the
emergence of chronicity might therefore reside in a
deficient substitution of mucus for acid and pepsin in
the gastric secretions.
Summary
A case of a steroid-induced prepyloric gastric ulcer in
a previously healthy male medical student, aged 23, is
described, with observations on gastric secretion and
plasma-pepsinogen and urine-pepsinogen levels before
and after the appearance, and during and after the
healing, of the ulcer.
These observations are compared with a previously
reported and very similar case.
It is concluded that changes in gastric secretion of
acid and pepsin played little part in the genesis of the
ulcers.
Healing of the ulcer, which took 7 days, was accom-
panied by the substitution of mucus for normal gastric
juice. This is regarded as probably a defence reaction,
whose failure may eventually lead to chronicity in
peptic ulceration.
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Preliminary Communications
EFFECT OF CARBUTAMIDE ON SERUM-
CHOLESTEROL LEVEL IN DIABETES
MELLITUS
IN the course of a clinical trial of carbutamide (B.Z.55)
in diabetes mellitus, we have noticed changes in the
serum-cholesterol level. In some, though not all, patients
the serum-cholesterol falls during the first few days of
therapy, and then rises rapidly, tending to regain its
original level even if the drug is still given. So far, these
events have been studied in only six patients, four of
whom showed the effect; and we are well aware that
serum-cholesterol levels sometimes fluctuate inexplicably.
Nevertheless, we think it desirable to bring our findings
to the notice of others using carbutamide and similar
compounds at a time when these drugs are still being
intensively investigated.
All the patients were studied in hospital while taking
a diet in which the content of fat and carbohydrate was
fixed. The fat was not analysed for its derivation or
composition, but it did not differ materially either in type
or in quantity from that taken by the public as a whole.
The distribution of fat and of carbohydrate among the
meals was constant from day to day.
The control of the diabetic state was judged mainly
by the 24-hour output of sugar in the urine ; but blood-
glucose was estimated 21/2 hours after breakfast, daily or
at not longer than 3-day intervals. At the same time,
blood was withdrawn for serum-cholesterol determination.
After a control period of not less than 4 days on the
fixed diet, carbutamide was given orally in a single dose
daily 21/2 hours after breakfast, starting with 5 g. on the
first day, 3 g. on the second day, and 1 g. on subsequent
days. If the drug did not adequately control the diabetes,
a few days without treatment were allowed to elapse
before starting insulin. While insulin was being given,
the same regime was followed.
Here we shall describe only two cases, the first showing
a good response of the diabetes to carbutamide, the
second a very small response.
Case 1.-A woman, aged 69. No family history of diabetes.
Height 5 ft. 21/2 in. Weight 8 st. 2 lb. Her maximum weight,
10 st. 7 lb.. was


























serum-cholesterol level. (The blood-glucose estimations are
not shown in the charts but the changes corresponded approxi-
mately with the urinary sugar output.)
Case 2.-Man, aged 58. No family history of diabetes.
Height 5 ft. 61i4 in. Weight 9 st. 8 lb. His maximum weight
